IFM Investors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16M Buy
174,744
+18,516
+12% +$1.62M 0.11% 175
2026
Q1
$13.3M Sell
156,228
-3,681
-2% -$328K 0.11% 173
2025
Q4
$12.6M Sell
159,909
-6,225
-4% -$488K 0.11% 176
2025
Q3
$13.2M Buy
166,134
+1,846
+1% +$157K 0.12% 160
2025
Q2
$14.9M Buy
164,288
+4,879
+3% +$445K 0.14% 133
2025
Q1
$14.9M Buy
159,409
+439
+0.3% +$39.3K 0.16% 118
2024
Q4
$14.5M Sell
158,970
-10,729
-6% -$1.02M 0.15% 130
2024
Q3
$17.6M Buy
169,699
+6,330
+4% +$645K 0.17% 113
2024
Q2
$15.9M Buy
163,369
+212
+0.1% +$19.6K 0.16% 115
2024
Q1
$14.7M Sell
163,157
-1,213
-0.7% -$103K 0.16% 118
2023
Q4
$13.1M Sell
164,370
-1,129
-0.7% -$84.9K 0.16% 121
2023
Q3
$11.8M Buy
165,499
+5,493
+3% +$411K 0.15% 129
2023
Q2
$12.3M Buy
160,006
+7,637
+5% +$591K 0.16% 126
2023
Q1
$11.5M Sell
152,369
-1,624
-1% -$121K 0.17% 115
2022
Q4
$12.1M Buy
153,993
+4,785
+3% +$359K 0.2% 103
2022
Q3
$10.5M Buy
149,208
+4,079
+3% +$320K 0.19% 110
2022
Q2
$11.6M Buy
145,129
+11,864
+9% +$928K 0.2% 99
2022
Q1
$10.1M Buy
133,265
+25,779
+24% +$2.04M 0.16% 130
2021
Q4
$9.17M Sell
107,486
-1,992
-2% -$156K 0.17% 116
2021
Q3
$8.27M Buy
109,478
+426
+0.4% +$33.8K 0.17% 116
2021
Q2
$8.87M Buy
109,052
+17,167
+19% +$1.4M 0.18% 117
2021
Q1
$7.24M Buy
91,885
+13,167
+17% +$1.03M 0.19% 109
2020
Q4
$6.73M Buy
78,718
+10,766
+16% +$890K 0.21% 96
2020
Q3
$5.24M Buy
67,952
+7,534
+12% +$574K 0.22% 92
2020
Q2
$4.43M Sell
60,418
-20,653
-25% -$1.47M 0.23% 91
2020
Q1
$5.4M Sell
81,071
-2,840
-3% -$200K 0.24% 96
2019
Q4
$5.78M Sell
83,911
-3,863
-4% -$263K 0.2% 108
2019
Q3
$6.45M Buy
87,774
+30,019
+52% +$2.18M 0.24% 90
2019
Q2
$4.14M Buy
57,755
+4,206
+8% +$299K 0.24% 90
2019
Q1
$3.67M Buy
53,549
+6,036
+13% +$390K 0.24% 94
2018
Q4
$2.83M Buy
47,513
+4,180
+10% +$262K 0.23% 94
2018
Q3
$2.9M Buy
43,333
+5,977
+16% +$398K 0.22% 99
2018
Q2
$2.42M Buy
37,356
+11,208
+43% +$733K 0.23% 100
2018
Q1
$1.87M Buy
26,148
+2,527
+11% +$182K 0.27% 83
2017
Q4
$1.78M Sell
23,621
-121
-0.5% -$8.84K 0.28% 79
2017
Q3
$1.73M Buy
23,742
+745
+3% +$53.7K 0.29% 79
2017
Q2
$1.71M Buy
22,997
+5,890
+34% +$437K 0.31% 74
2017
Q1
$1.25M Buy
17,107
+6,312
+58% +$442K 0.32% 72
2016
Q4
$706K Buy
+10,795
New +$740K 0.33% 75

Other funds holding CL

IFM Investors's CL Position: Q2 2026 in Review

IFM Investors increased its Colgate-Palmolive (CL) stake by 12% in Q2 2026, buying an estimated $1.62M and bringing the position to 174,744 shares worth $16M. The position accounts for 0.11% of the portfolio, ranked #175.

IFM Investors first reported a position in CL in Q4 2016 and has held it in 39 quarters since. The position peaked at $17.6M in Q3 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • IFM Investors held 174,744 shares of Colgate-Palmolive worth $16M as of Q2 2026.
  • IFM Investors bought 18,516 Colgate-Palmolive shares in Q2 2026, an estimated $1.62M.
  • Colgate-Palmolive made up 0.11% of IFM Investors's portfolio in Q2 2026, its #175 holding.
  • IFM Investors first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 39 quarters since.
  • IFM Investors's Colgate-Palmolive position peaked at $17.6M in Q3 2024.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.